Pharmascience Inc. v Janssen Inc. (Supreme Court File No. 41209)
On October 9, 2025, Belmore Neidrauer represented Janssen in the Supreme Court of Canada in a case dealing with the law on patentable subject matter (method of medical treatment law).
This appeal was from Pharmascience Inc. v Janssen Inc, 2024 FCA 23 (FCA Decision).
This case relates to Canadian Patent No. 2,655,335 covering Janssen’s paliperidone palmitate product marketed under the brand name INVEGA SUSTENNA®.
The decision is under reserve.
Supreme Court of Canada | 41209
We are proud of our outstanding team!
